Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 99 | 101 | +2 |
| Shares | 20.7M | 33.0M | +12.3M (+59.5%) |
| Value | $48.4M | $57.5M | +$9.01M (+18.6%) |
New holders (20)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 1,485,008 | $2.58M | 0.19% |
| Diadema Partners LP | 533,682 | $928.6K | 0.55% |
| 683 Capital Management, LLC | 248,790 | $432.9K | 0.04% |
| Omers Administration Corp | 223,000 | $388.0K | 0.00% |
| Bridgeway Capital Management, LLC | 173,000 | $301.0K | 0.01% |
| Persistent Asset Partners Ltd | 142,164 | $247.4K | 0.12% |
| Marshall Wace, LLP | 82,331 | $143.3K | 0.00% |
| Hudson Bay Capital Management LP | 50,677 | $88.2K | 0.00% |
| Virtu Financial LLC | 44,040 | $77.0K | 0.00% |
| Lighthouse Investment Partners, LLC | 30,600 | $53.2K | 0.00% |
| Wolverine Asset Management LLC | 30,500 | $53.1K | 0.00% |
| Baader Bank INC | 36,767 | $39.5K | 0.00% |
| Mayflower Financial Advisors, LLC | 12,559 | $21.9K | 0.00% |
| HighTower Advisors, LLC | 11,149 | $19.4K | 0.00% |
| Pioneer Family Office, LLC | 291 | $506 | 0.00% |
| Smartleaf Asset Management LLC | 83 | $146 | 0.00% |
| Pinnacle Wealth Planning Services, Inc. | 41 | $71 | 0.00% |
| International Assets Investment Management, LLC | 36 | $63 | 0.00% |
| Strive Financial Group ,LLC | 1 | $2 | 0.00% |
| CWM, LLC | 146 | $0 | 0.00% |
Sold out (18)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| GMT Capital Corp | 126,119 | $295.1K |
| Headlands Technologies LLC | 110,068 | $257.6K |
| HRT Financial LP | 65,065 | $152.0K |
| Dimensional Fund Advisors LP | 37,991 | $89.1K |
| Zacks Investment Management | 19,455 | $45.5K |
| Colony Group, LLC | 14,289 | $33.4K |
| Citigroup Inc | 12,977 | $30.4K |
| Citadel Advisors LLC | 12,402 | $29.0K |
| Charles Schwab Investment Management Inc | 12,330 | $28.9K |
| SG Americas Securities, LLC | 11,497 | $27.0K |
| Meridian Wealth Management, LLC | 10,000 | $23.4K |
| Crowley Wealth Management, Inc. | 404 | $945 |
| Principal Securities, Inc. | 177 | $414 |
| Optiver Holding B.V. | 24 | $56 |
| Groupe la Francaise | 20 | $42 |
| Wealthspire Advisors, LLC | 15 | $36 |
| Johnson Financial Group, Inc. | 4 | $10 |
| Northwestern Mutual Wealth Management Co | 1 | $2 |